Cellular Biomedicine Group Inc (CBMG):企業の財務・戦略的SWOT分析

◆英語タイトル:Cellular Biomedicine Group Inc (CBMG) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH451369FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cellular Biomedicine Group Inc (CBMG) is a clinical stage biopharmaceutical firm that develops biomedicine, immunotherapy products for cancer and stem cell therapies to address patient specific medical conditions. The firm’s products comprise clinical treatment protocols for the treatment of knee osteoarthritis, cancer, asthma and chronic obstructive pulmonary diseases. It offers treatment protocol services such as orthopaedic diseases including osteoarthritis and tissue damage; and other indications. CBMG utilizes proprietary cell based technologies to produce raw material, manufacture cells, and conduct cell banking and distribution. The firm has operations in Hong Kong, China and the US. CBMG is headquartered in Cupertino, California, the US.

Cellular Biomedicine Group Inc Key Recent Developments

Feb 19,2021: 14:55 ET Cellular Biomedicine Group, Inc. Announces Completion of Merger Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”) today announced the completion of the merger (the “Merger”) of the Company…
Feb 08,2021: Cellular Biomedicine Group, Inc. Stockholders Approve Merger
Nov 09,2020: Cellular Biomedicine Group reports Q3 2020 financial results and business highlights
Aug 12,2020: Cellular Biomedicine Group (CBMG) reports Q2, H1 2020 financial results and business highlights
Jul 13,2020: Cellular Biomedicine Group (CBMG) hosts R&D showcase and provides updates to clinical programs

This comprehensive SWOT profile of Cellular Biomedicine Group Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cellular Biomedicine Group Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cellular Biomedicine Group Inc – Key Information
Cellular Biomedicine Group Inc – Overview
Cellular Biomedicine Group Inc – Key Employees
Cellular Biomedicine Group Inc – Key Employee Biographies
Cellular Biomedicine Group Inc – Key Operational Heads
Cellular Biomedicine Group Inc – Major Products and Services
Cellular Biomedicine Group Inc – History
Cellular Biomedicine Group Inc – Company Statement
Cellular Biomedicine Group Inc – Locations And Subsidiaries
Cellular Biomedicine Group Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cellular Biomedicine Group Inc – Business Description
Cellular Biomedicine Group Inc – Corporate Strategy
Cellular Biomedicine Group Inc – SWOT Analysis
SWOT Analysis – Overview
Cellular Biomedicine Group Inc – Strengths
Cellular Biomedicine Group Inc – Weaknesses
Cellular Biomedicine Group Inc – Opportunities
Cellular Biomedicine Group Inc – Threats
Cellular Biomedicine Group Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Cellular Biomedicine Group Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cellular Biomedicine Group Inc, Key Information
Cellular Biomedicine Group Inc, Key Ratios
Cellular Biomedicine Group Inc, Share Data
Cellular Biomedicine Group Inc, Major Products and Services
Cellular Biomedicine Group Inc, History
Cellular Biomedicine Group Inc, Key Employees
Cellular Biomedicine Group Inc, Key Employee Biographies
Cellular Biomedicine Group Inc, Key Operational Heads
Cellular Biomedicine Group Inc, Other Locations
Cellular Biomedicine Group Inc, Subsidiaries
Cellular Biomedicine Group Inc, Key Competitors
Cellular Biomedicine Group Inc, SWOT Analysis
Cellular Biomedicine Group Inc, Ratios based on current share price
Cellular Biomedicine Group Inc, Annual Ratios
Cellular Biomedicine Group Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cellular Biomedicine Group Inc (CBMG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Buckeye Partners LP (BPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Buckeye Partners LP (Buckeye) is a provider of midstream logistic solutions. It owns and operates a diversified network of integrated assets for the transportation, storage, processing and marketing of liquid petroleum products. The company transports liquid petroleum products, including gas …
  • Kallpa Generacion SA:企業の戦略的SWOT分析
    Kallpa Generacion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • PsychoGenics Inc-製薬・医療分野:企業M&A・提携分析
    Summary PsychoGenics Inc (PsychoGenics) is an preclinical contract research organization that offers contract research, standard and customized preclinical services and drug discovery services. The organization offers various behavioral tests to drug candidates in the areas of pain and inflammation, …
  • International AIDS Vaccine Initiative:製薬・医療:M&Aディール及び事業提携情報
    Summary International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. Its pro …
  • Electrica SA (EL):電力:M&Aディール及び事業提携情報
    Summary Electrica SA (Electrica) is a power utility that distributes and supplies electricity. Its services include electricity supply, distribution, and trading, and power distribution networks operations and management, and design and consultation for aerial and subterranean power networks. It als …
  • Electromagnetic Geoservices ASA (EMGS):企業の財務・戦略的SWOT分析
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …
  • PanAust Ltd:企業の戦略・SWOT・財務分析
    PanAust Ltd - Strategy, SWOT and Corporate Finance Report Summary PanAust Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Avaya Inc:企業の戦略的SWOT分析
    Avaya Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Mapfre SA (MAP):企業の財務・戦略的SWOT分析
    Mapfre SA (MAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • HCA Healthcare Inc (HCA)-製薬・医療分野:企業M&A・提携分析
    Summary HCA Healthcare Inc (HCA), formerly known as HCA Holdings Inc, is a health care services company that provides a wide range of services in specialties including internal medicine; general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. It also offers outpatient and an …
  • National Bank of Canada:企業の戦略・SWOT・財務情報
    National Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary National Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Li Ning Company Ltd (2331)
    Li Ning Company Ltd (2331) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • IDT Biologika GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary IDT Biologika GmbH (IDT Biologika), a subsidiary of Klocke Pharma-Service GmbH, is a vaccines and pharmaceuticals manufacturer. The company offers contract manufacturing services. It provides integrated development and manufacturing services in four major areas of animal health, vaccines, ph …
  • Sino Land Co Ltd:企業の戦略・SWOT・財務情報
    Sino Land Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sino Land Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Foundation Medicine Inc (FMI)-医療機器分野:企業M&A・提携分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for soli …
  • Eurus Energy America Corp:電力:M&Aディール及び事業提携情報
    Summary Eurus Energy America Corp (Eurus Energy) a subsidiary of Eurus Energy Holdings Corp, is a renewable energy company that develops wind and solar energy projects. The company provides wind project services including land and construction, data collection, operation and maintenance services. It …
  • R-Biopharm AG-医療機器分野:企業M&A・提携分析
    Summary R-Biopharm AG (R-Biopharm), a subsidiary of Rohm GmbH is a clinical diagnostics center that test solutions for clinical diagnostics and food and feed analysis. The center offers test systems in the areas of infectological stool diagnostics, serological infection and allergy diagnostics for c …
  • Wabash Valley Power Association, Inc.:企業の戦略的SWOT分析
    Wabash Valley Power Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Kforce Inc (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Canadian Utilities Ltd (CU):電力:M&Aディール及び事業提携情報
    Summary Canadian Utilities Ltd (CUL), an ATCO company, is an electric utility. The company carries out electricity and natural gas distribution and transmission operations. It constructs and maintains electrical transmission and distribution lines and has stakes in generating plants through subsidia …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆